EPIC Program Annual Data Tables 2008-2009 Appendix: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification*
Therapeutic Class** Number
of Claims
Percent
of Claims
EPIC
 Payments  
Number of
Participants
Total***4,408,50443.52%$137,160,498
BETA-ADRENERGIC BLOCKING AGENT780,3227.69%$8,456,584146,638
HMG-COA REDUCTASE INHIBITORS717,0247.08%$30,493,147152,200
PROTON-PUMP INHIBITORS450,5064.45%$36,312,55195,289
ANGIOTENSIN-CONVERTING ENZYME445,2704.40%$2,850,53092,004
ANTIDEPRESSANTS371,8313.67%$9,778,44866,394
ANGIOTENSIN II RECEPTOR ANTAGO371,3323.67%$20,245,72573,090
DIHYDROPYRIDINES361,1583.57%$6,657,85772,191
THYROID AGENTS316,4853.12%$2,016,28358,703
OPIATE AGONISTS309,1173.05%$6,486,37580,038
BETA-ADRENERGIC AGONISTS285,4592.82%$13,862,99846,261

* Table VII provides the percent of adjudicated claims for the program year (October 1, 2008 through September 30, 2009) as they fall into particular categories of Therapeutic Class.

** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.